Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus

Archives of Dermatology

Volumn 144, Issue 5, 2008, Pages 591-598

  Eisendle, Klaus ^a   Grabner, Tanja ^a   Kutzner, Heinz ^b   Zelger, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Dermatopathological Private Laboratory Friedrichshafen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS; ADULT; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BORRELIA BURGDORFERI GROUP; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; LYME DISEASE; MALE; MICROSCOPY; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 44249089731     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.5.591     Document Type: Article

References (47)

1. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 1995;32(3):393-416.
2. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353(9166):1777-1783.
3. Marini A, Blecken S, Ruzicka T, Hengge UR. Lichen sclerosus: new aspects of pathogenesis and treatment [in German]. Hautarzt. 2005;56(6):550-555.
4. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol. 2005;48(4):808-817.
5. Shono S, Imura M, Ota M, Osaku A, Shinomiya S, Toda K. Lichen sclerosus et atrophicus, morphea, and coexistence of both diseases: histological studies using lectins. Arch Dermatol. 1991;127(9):1352-1356.
6. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70(11):1068-1076.
7. Asbrink E, Brehmer-Andersson E, Hovmark A. Acrodermatitis chronica atrophicans-a spirochetosis: clinical and histopathological picture based on 32 patients: course and relationship to erythema chronicum migrans Afzelius. Am J Dermatopathol. 1986;8(3):209-219.
8. Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am J Dermatopathol. 1987;9(5):374-379.
9. Aberer E, Kollegger H, Kristoferitsch W, Stanek G. Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol. 1988;19(5, pt 1):820-825.
10. Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol. 1990;12(4):357-362.
11. Schempp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993;100(5):717-720.
12. Ranki A, Aavik E, Peterson P, Schauman K, Nurmilaakso P. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol. 1994;102(3):339-345.
13. Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol. 1995;33(4):617-620.
14. De Vito JR, Merogi AJ, Vo T, et al. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol. 1996;23(4):350-358.
15. Fujiwara H, Fujiwara K, Hashimoto K, et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol. 1997;133(1):41-44.
16. Colomé-Grimmer MI, Payne DA, Tyring SK, Sanchez RL. Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States [letter]. Arch Dermatol. 1997;133(9):1174.
17. Alonso-Llamazares J, Persing DH, Anda P, Gibson LE, Rutledge BJ, Iglesias L. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain: a prospective study and literature review. Acta Derm Venereol. 1997;77(4):299-304.
18. Aberer E, Schmidt BL, Breier F, Kinaciyan T, Luger A. Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma annulare and lichen sclerosus et atrophicus. Arch Dermatol. 1999;135(2):210-212.
19. Özkan S, Atabey N, Fetil E, Erkizan V, Günes AT. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol. 2000;39(4):278-283.
20. Breier F, Khanakah G, Stanek G, et al. Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol. 2001;144(2):387-392.
21. Schmutzhard E, Stanek G, Pletschette M, et al. Infections following tickbites: tick borne encephalitis and Lyme borreliosis - a prospective epidemiological study from Tyrol. Infection. 1988;16(5):269-272.
22. Plörer A, Sepp N, Schmutzhard E, et al. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J Invest Dermatol. 1993;100(2):103-109.
23. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484-509.
24. De Koning J, Bosma RB, Hoogkamp-Korstanje JA. Demonstration of spirochetes in patients with Lyme disease with a modified silver stain. J Med Microbiol. 1987;23(3):261-267.
25. Aberer E, Duray PH. Morphology of Borrelia burgdorferi: structural patterns of cultured borreliae in relation to staining methods. J Clin Microbiol. 1991;29(4):764-772.
26. Aberer E, Kersten A, Klade H, Poitschek C, Jurecka W. Heterogeneity of Borrelia burgdorferi in the skin. Am J Dermatopathol. 1996;18(6):571-579.
27. Berger BW, Kaplan MH, Rothenberg IR, Barbour AG. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol. 1985;13(3):444-449.
28. Melchers W, Meis J, Rosa P, et al. Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease. J Clin Microbiol. 1991;29(11):2401-2406.
29. Guy EC, Stanek G. Detection of Borrelia burgdorferi in patients with Lyme disease by the polymerase chain reaction. J Clin Pathol. 1991;44(7):610-611.
30. Wienecke R, Neubert U, Volkenandt M. Molecular detection of Borrelia burgdorferi in formalin-fixed paraffin-embedded lesions of Lyme disease. J Cutan Pathol. 1993;20(5):385-388.
31. Moter SE, Hofmann H, Wallich R, Simon MM, Kramer MD. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema chronicum migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol. 1994;32(12):2980-2988.
32. von Stedingk LV, Olsson I, Hanson HS, Asbrink E, Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 1995;14(1):1-5.
33. Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol. 1998;36(9):2658-2665.
34. Eisendle K, Grabner T, Zelger B. Focus floating microscopy: "gold standard" for cutaneous borreliosis? Am J Clin Pathol. 2007;127(2):213-222.
35. Schwartz JJ, Gazumyan A, Schwartz I. rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi. J Bacteriol. 1992;174(11):3757-3765.
36. Shelley WB, Shelley ED, Grunenwald MA, Anders TJ, Ramnath A. Long-term antibiotic therapy for balanitis xerotica obliterans. J Am Acad Dermatol. 1999;40(1):69-72.
37. Shelley WB, Shelley ED, Amurao CV. Treatment of lichen sclerosus with antibiotics. Int J Dermatol. 2006;45(9):1104-1106.
38. Schewe C, Rizzello M, Dietel M, Hauptmann S. PCR based diagnosis in pathology [in German]. Pathologe. 2000;21(3):218-228.
39. Földvári G, Farkas R, Lakos A. Borrelia spielmanii erythema migrans, Hungary. Emerg Infect Dis. 2005;11(11):1794-1795.
40. Rebaudet S, Parola P. Epidemiology of relapsing fever borreliosis in Europe. FEMS Immunol Med Microbiol. 2006;48(1):11-15.
41. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993;17(4):708-717.
42. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet. 1998;352(9127):557-565.
43. Bergmann AR, Schmidt B, Derler AM, Aberer E. Importance of sample preparation for molecular diagnosis of Lyme borreliosis from urine. J Clin Microbiol. 2002;40(12):4581-4584.
44. Behar SM, Porcelli SA. Mechanisms of autoimmune disease induction: the role of the immune response to microbial pathogens. Arthritis Rheum. 1995;38(4):458-476.
45. Dickie RJ, Horne C, Sutherland H, Bewsher PD, Stankler L. Direct evidence of localised immunological damage in vulvar lichen sclerosus et atrophicus. J Clin Pathol. 1982;35(12):1395-1397.
46. Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid. 2006;16(3):225-236.
47. Vaccaro M, Guarneri F, Borgia F, Cannavo SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12(12):1147-1148.